QT interval correction assessment in the anesthetized guinea pig.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of pharmacological and toxicological methods

• Publication date

  2015-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.vascn.2015.05.007PMID 26001325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium.

  2014cited by this paper
• Pattern recognition analysis of digital ECGs: decreased QT measurement error and improved precision compared to semi-automated methods.

  2013cited by this paper
• The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.

  2013cited by this paper
• Characterization of the Human QT Interval: Novel Distribution‐Based Assessment of the Repolarization Effects of Moxifloxacin

  2012cited by this paper
• The electro‐mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes risk

  2012cited by this paper
• The Electro‐Mechanical window: a risk marker for Torsade de Pointes in a canine model of drug induced arrhythmias

  2010cited by this paper
• Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken

  2009cited by this paper
• The effect of changes in core body temperature on the QT interval in beagle dogs: a previously ignored phenomenon, with a method for correction

  2008cited by this paper
• Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model

  2008cited by this paper
• Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.

  2008cited by this paper
• QT prolongation in guinea pigs for preliminary screening of torsadogenicity of drugs and drug‐candidates. II

  2007cited by this paper
• Different species require different correction factors for the QT interval

  2007cited by this paper
• Characterization of the halothane-anesthetized guinea-pig heart as a model to detect the K+ channel blocker-induced QT-interval prolongation.

  2006cited by this paper
• Sympathomimetic Infusion and Cardiac Repolarization: The Normative Effects of Epinephrine and Isoproterenol in Healthy Subjects

  2006cited by this paper
• Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.

  2006cited by this paper
• Magnitude of Error Introduced by Application of Heart Rate Correction Formulas to the Canine QT Interval

  2006cited by this paper
• Dynamic Beat-to-Beat Modeling of the QT-RR Interval Relationship: Analysis of QT Prolongation during Alterations of Autonomic State versus Human Ether a-go-go-Related Gene Inhibition

  2005cited by this paper
• Novel Method to Assess Cardiac Electrophysiology in the Rat: Characterization of Standard Ion Channel Blockers

  2005cited by this paper
• TRIad: foundation for proarrhythmia (triangulation, reverse use dependence and instability).

  2005cited by this paper
• A Pharmacokinetic‐pharmacodynamic Model for the Quantitative Prediction of Dofetilide Clinical QT Prolongation from Human Ether‐a‐go‐go‐related Gene Current Inhibition Data

  2005cited by this paper
• A new method to calculate the beat-to-beat instability of QT duration in drug-induced long QT in anesthetized dogs.

  2005cited by this paper
• Cardiovascular parameters in anaesthetized guinea pigs: a safety pharmacology screening model.

  2005cited by this paper
• QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles.

  2003cited by this paper
• Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.

  2003cited by this paper
• Drug induced QT prolongation and torsades de pointes

  2003cited by this paper
• In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity

  2002cited by this paper
• Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

  2002cited by this paper
• Density and Kinetics of IKr and IKs in Guinea Pig and Rabbit Ventricular Myocytes Explain Different Efficacy of IKs Blockade at High Heart Rate in Guinea Pig and Rabbit: Implications for Arrhythmogenesis in Humans

  2001cited by this paper
• Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle‐aged subjects

  1999cited by this paper
• The heart rate-corrected QT interval of conscious beagle dogs: a formula based on analysis of covariance.

  1998cited by this paper
• AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS.

  1997cited by this paper
• QT corrected for heart rate and relation between QT and RR intervals in beagle dogs.

  1997cited by this paper
• Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence.

  1996cited by this paper
• Ketamine and its use in the pig. Recommendations of the Consensus meeting on Ketamine Anaesthesia in Pigs, Bergen 1994. Ketamine Consensus Working Group.

  1996cited by this paper
• The novel class III antiarrhythmics NE-10064 and NE-10133 inhibit IsK channels expressed in Xenopus oocytes and IKs in guinea pig cardiac myocytes.

  1994cited by this paper
• Sympathetic and vagal influences on rate-dependent changes of QT interval in healthy subjects.

  1991cited by this paper
• Direct electrophysiological actions of pentobarbital at concentrations achieved during general anesthesia.

  1990cited by this paper
• An improved method to correct the QT interval of the electrocardiogram for changes in heart rate.

  1989cited by this paper
• Hysteresis of the ventricular paced QT interval in response to abrupt changes in pacing rate.

  1988cited by this paper
• Comparison of effects of three anesthetic agents on induction of ventricular tachycardia in a canine model of myocardial infarction.

  1988cited by this paper
• Influence of the autonomic nervous system on the Q-T interval in man.

  1982cited by this paper

• Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer

  2023cites this paper
• Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels

  2023cites this paper
• Enzastaurin cardiotoxicity: QT interval prolongation, negative inotropic responses and negative chronotropic action.

  2023cites this paper
• Angiotensin II type 1 receptor blockade attenuates gefitinib-induced cardiac hypertrophy via adjusting angiotensin II-mediated oxidative stress and JNK/P38 MAPK pathway in a rat model

  2022cites this paper
• Mechanisms of gefitinib-induced QT prolongation.

  2021cites this paper
• Differentiating multichannel block on the guinea pig ECG: Use of Tpeak-Tend and J-Tpeak.

  2021cites this paper
• Drug-induced QT prolongation: Concordance of preclinical anesthetized canine model in relation to published clinical observations for ten CiPA drugs.

  2020cites this paper
• Unanesthetized Rodents Demonstrate Insensitivity of QT Interval and Ventricular Refractory Period to Pacing Cycle Length

  2018cites this paper
• Computerized electrocardiogram in agoutis (Dasyprocta prymnolopha Wagler, 1831) anesthetized with ketamine and midazolam

  2017cites this paper
• A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate

  2017cites this paper
• Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells

  2017cites this paper
• Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistry

  2017cites this paper
• Shortening of the electromechanical window in the ketamine/xylazine-anesthetized guinea pig model to assess pro-arrhythmic risk in early drug development.

  2016cites this paper
• Recalibration of nonclinical safety pharmacology assessment to anticipate evolving regulatory expectations.

  2016cites this paper
• Assessment of the clinical cardiac drug‐drug interaction associated with the combination of hepatitis C virus nucleotide inhibitors and amiodarone in guinea pigs and rhesus monkeys

  2016cites this paper
• The shifting landscape of safety pharmacology in 2015.

  2015cites this paper